Header cover image

Pharmaceuticals & Biotech Biotech Breakthroughs

UPDATED May 08, 2024

Companys with strong funding and high growth potential

102 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOVN.F

BioInvent International		kr4.700%n/akr2.7bkr12.58PS9.2xE62.0%n/a

AXSM

Axsome Therapeutics		US$75.682.0%-2.9%US$3.6bUS$123.56PS14.3xE65.1%n/a

ZVRA

Zevra Therapeutics		US$5.168.6%21.1%US$215.9mUS$19.00PS7.8xE68.0%n/a

RCEL

AVITA Medical		US$8.962.8%-43.0%US$231.2mUS$25.90PS4.6xE62.0%n/a

SGEN

Seagen		US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

IMGN

ImmunoGen		US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

IPHY.F

Innate Pharma		€2.20-17.0%-24.9%€185.1m€6.02PS3xE33.0%n/a

AVHH.L

AVITA Medical		US$1.7715.7%n/aUS$231.2mUS$5.12PS4.6xE62.0%n/a

CLTE.F

Calliditas Therapeutics		kr7.550%n/akr5.8bkr18.65PS20.7xE60.2%n/a

ARDX

Ardelyx		US$8.4824.9%97.7%US$2.0bUS$13.83PS12.5xE60.7%n/a

ITCI

Intra-Cellular Therapies		US$67.00-4.7%4.1%US$7.1bUS$90.60PS13.8xE60.6%n/a

ARUX.F

Acrux		AU$0.0310%-29.3%AU$20.1mn/aPS1.8xE115.3%0%

CALT

Calliditas Therapeutics		kr20.563.1%-16.4%kr6.0bkr38.19PS5xE49.9%n/a

IPHA

Innate Pharma		€2.633.5%-10.4%€185.1m€7.20PS3xE33.0%n/a

AVDL

Avadel Pharmaceuticals		US$16.25-11.2%n/aUS$1.5bUS$22.50PS26.7xE57.9%n/a

ISEE

IVERIC bio		US$39.950.9%236.3%US$5.5bUS$40.00PB11.6xE59.0%n/a

SPRY

ARS Pharmaceuticals		US$9.06-2.9%100.4%US$917.6mUS$19.00PS29262.1xE56.2%n/a

MGTX

MeiraGTx Holdings		US$5.143.0%-17.1%US$346.0mUS$21.60PS23.6xE52.8%n/a

GTHX

G1 Therapeutics		US$4.29-3.4%53.8%US$224.3mUS$8.50PS2.7xE48.2%n/a

IVBI.Y

Innovent Biologics		HK$19.480%n/aHK$64.9bHK$26.95PS9.7xE51.3%n/a

MDGL

Madrigal Pharmaceuticals		US$208.04-3.7%-27.8%US$4.4bUS$371.79PB5.2xE65.5%n/a

ALDX

Aldeyra Therapeutics		US$4.07-3.3%-60.7%US$241.8mUS$9.25PB2.1xE61.8%n/a

CSPH.F

CStone Pharmaceuticals		HK$0.120%n/aHK$1.4bn/aPS2.7xE56.9%n/a

CAPR

Capricor Therapeutics		US$5.372.5%30.7%US$169.2mUS$21.00PS6.7xE59.4%n/a
Page 1 of 5
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.